DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: EVOXAC

Summary for Tradename: EVOXAC

Patents:1
Applicants:1
NDAs:1
Suppliers: see list3
drug
patent expirations by year for
 EVOXAC

Pharmacology for Tradename: EVOXAC

Clinical Trials for: EVOXAC

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions
Status: Completed Condition: Dry Mouth

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions
Status: Completed Condition: Dry Mouth

Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia
Status: Recruiting Condition: Xerostomia

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
Status: Completed Condition: Dry Mouth

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Status: Completed Condition: Head and Neck Cancer; Oral Complications; Radiation Toxicity

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo
EVOXAC
cevimeline hydrochloride
CAPSULE;ORAL020989Jan 11, 2000RXYes5,340,821<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: EVOXAC

Drugname Dosage Strength RLD Submissiondate
cevimeline hydrochlorideCapsules30 mgEvoxac2/27/2009

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc